Back to search
FDAFDA · Food and drugs·Recall number D-0362-2024

Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-097-42

Published March 6, 2024 · Recall initiated: February 20, 2024

Summary

FDA records drug Class II recall D-0362-2024, published March 6, 2024 and initiated February 20, 2024. Recalling firm: Denver Solutions, LLC DBA Leiters Health; Status: Ongoing; Reported quantity: 10,020 vials; Lot: Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Denver Solutions, LLC DBA Leiters Health
Distributor
Nationwide in the USA
Lot
Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-097-42 recalled?

Yes. FDA published recall D-0362-2024 on March 6, 2024. Reported hazard: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

What should I do if I have this product?

Voluntary: Firm initiated · Letter